Contrast enhancement following coiling of intracranial aneurysms in 3T MRI and its relationship to aneurysm recurrence following endovascular treatment

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

DRKS

Registry ID

DRKS00014644

Enrollment

100

Registered

2018-05-07

Start date

2018-03-16

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I67.10

Interventions

Group 1: Following Coiling a minimum of 4 MRI Follow-up examinations are recommended. In these follow-up examination the patients will receive gadolinium containing contrast medium in the usual dose.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Clinically indicated follow-up MRI/MRA examination after coiling of a ruptured or unruptured cerebral aneurysm.

Exclusion criteria

Exclusion criteria: Known Contraindication to Gadolinium contrast agents. Patients, who for any reason are unable to personally give an informed consent to the study

Design outcomes

Primary

Measure	Time frame
Contrast enhancement of treated intracranial aneurysms in serial MRI-examinations 6, 18, 36 and 60 months following treatment.	—

Secondary

Measure	Time frame
Recurrence following Coiling in serial MRI/ MR-angiographic examinations 6, 18, 36 and 60 months following treatment.	—

Countries

Germany

Contacts

Public ContactSamer Elsheikh

Klinik für Neuroradiologie. Universitätsklinik Freiburg.

samer.elsheikh@gmail.com004976127051710

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 8, 2026